A PROCESS FOR SYNTHESIS OF 1-(AMINOMETHYL)CYCLOHEXANE ACETIC ACID HYDROCHLORIDE

PROCEDE DE SYNTHESE DE CHLORHYDRATE D'ACIDE ACETIQUE 1-(AMINOMETHYL)CYCLOHEXANE

English Abstract

A process for synthesis of 1-(aminomethyl)cyclohexane acetic acid
hydrochloride (Gabapentin hydrochloride) comprising: a) Reaction of a mixture
of acetic anhydride/ammonium acetate with 1,1-cyclohexane~diacetic acid to
yield 3,3-pentamethylene glutarimide; b) Treatment of 3,3-pentamethylene
glutarimide with sodium hydroxide in an aqueous solution up to dissolution,
dripping the solution thus obtained into a to sodium hydroxide/sodium
hypochlorite mixture, which is also aqueous, followed by acidification with
hydrochloric acid to yield gabapentine hydrochloride.

French Abstract

L'invention concerne un procédé de synthèse de chlorhydrate d'acide acétique 1-(aminomethyl)cyclohexane (chlorhydrate de Gabapentine) consistant: a) à faire réagir un mélange d'acétate d'ammonium/anhydre acétique avec de l'acide 1,1-cyclohexane-diacétique afin d'obtenir 3,3-pentaméthylène glutarimide; b) à traiter 3,3-pentamethylene glutarimide avec de l'hydroxyde de sodium dans une solution aqueuse jusqu'à la dissolution, à égoutter la solution ainsi obtenue dans un mélange d'hypochlorite de sodium/hydroxyde de sodium, qui est également aqueux, suivi de l'acidification avec de l'acide hydrochlorique afin d'obtenir de l'hydrochloride de gabapentine.

Claims

5
CLAIMS
1. A process for synthesis of gabapentin hydrochloride comprising:
a) Reaction of a mixture of acetic anhydride/ammonium acetate with 1,1-
cyclohexane diacetic acid to yield 3,3-pentamethylene glutarimide;
b) Treatment of 3;3-pentamethylene glutarimide with sodium hydroxide in an
aqueous solution up to dissolution, dripping the solution obtained into a
sodium
hydroxide/sodium hypochlorite mixture, which is also aqueous, followed by
acidification with hydrochloric acid to yield gabapentine hydrochloride.
2. The process according to Claim 1, wherein the reaction of step a) is
conducted
at a temperature of 160°C to 170°C.
3. The process according to Claim 1, wherein extinguishing of the reaction of
step
a) is achieved by gradual cooling, first at a temperature of 90°C-
110°C with
consequent addition to the reaction environment of a water/secondary butyl
alcohol mixture, and subsequently, completing said cooling to room
temperature,
the pH being brought to a basic value; namely, a pH of approximately 9 is
achieved by treating with 30% aqueous ammonia.
4. The process according to Claim 1, wherein in step b) the treatment of 3,3-
pentamethyl glutarimide with sodium hydroxide in an aqueous solution is
carried
out at a temperature of 50°C to 80°C, in water with 30% sodium
hydroxide.
5. The process according to Claim 1, wherein in step b) the sodium
hydroxide/sodium hypochlorite mixture consists of sodium hydroxide: 30% and
sodium hypochlorite: 15%.
6. The process according to Claim 1, wherein instep b) the treatment with
sodium
hydroxide/sodium hypochlorite occurs at a temperature of 0°C to
50°C, more
preferably of 0°C to 30°C.
7. The process according to Claim 1, wherein in step b) the acidification is
carried
out with aqueous hydrochloric acid.
8. The process according to Claim 1, wherein in step b) the acidification is
carried
out at a temperature of 0°C to 50°C, preferably at room
temperature,
9. The process according to Claim 1, wherein in step b) the acidification with
hydrochloric acid is followed by a treatment with an aqueous solution of
sodium
bisulphite, under stirring at 40°C-60°C, up to complete
elimination of the excess of

6
chlorine.
10. Gabapentin form II with a purity measured via HPLC > 99.5%, a content of
lactam < 0.10% and a content of chloride anions < 100 ppm, obtained from
Gabapentin hydrochloride prepared according to the process of claims 1-9.

Description

CA 02500400 2005-03-29
WO 2004/031126 PCT/EP2003/010866
1
A PROCESS FOR SYNTHESIS OF 1-(AMINOMETHYL)CYCLOHEXANE
ACETIC ACID HYDROCHLORIDE
FIELD OF THE INVENTION
The present invention relates to a process for synthesis of 1-
s (aminomethyl)cyclohexane-acetic acid hydrochloride (GABAPENTIN
hydrochloride).
PRIOR ART
GABAPENTIN, which is characterized by the following structural formula (I)
HZN ~COOH
(I)
is an active principle mainly used' in human therapy for treating cerebral
disorders,
such as epilepsy ("Drugs of the future", vol. 9, N° 6, 1984, pp. 418-
419).There
exist various processes, which are described in the prior art, for the
synthesis of
this molecule as free-base gabapentin. Amongst these processes, there are the
is ones described in the U.S. patents US 5,132,451, 5,095,148, 5,068,413. Each
of
these methods involves the formation of a cyanic intermediate, which is
subjected
to hydrogenation in particularly severe conditions, which are impracticable at
an
industrial size for producing the free amino acid gabapentin.
A valid alternative, at an industrial size, for producing free-base gabapentin
is its
2o preparation starting from the corresponding hydrochloride salt, subtracting
the
chloride. ion, to make available the molecule of gabapentin in the form of a
free
amino acid, according to techniques that are well known to the art
(WO 98/ 28255).
Therefore the need was felt to provide new processes for synthesis of
gabapentin
2s hydrochloride that may be Basely sealed up to industrial size, which are
characterized by just a few steps of synthesis with high yields, starting from
reagents that are readily available on the market, to yield gabapentin
hydrochloride of high purity and in amounts such as to render industrially
applicable the subsequent process of conversion from gabapentin hydrochloride
to

CA 02500400 2005-03-29
WO 2004/031126 PCT/EP2003/010866
2
free-base gabapentin.
SUMMARY
A new process for the synthesis of gabapentin hydrochloride has now been
found,
via the formation of the intermediate: 3,3-pentamethylene glutarimide or 3-
s Azaspiro[5.5]-undecane-2,4-dione, just two steps of synthesis in conditions
that
are readily sealed up to industrial size, commercially available reagents,
with
yields of between 85% and 95% and an end product, gabapentin hydrochloride, of
high purity (>95.5%, by HPLC).
The applicant has unexpectedly found a new process for synthesis of gabapentin
io hydrochloride, comprising:
Reaction of a mixture of acetic anhydride/ammonium acetate with 1,1-
cyclohexane diacetic acid at 160°C-170°C, followed by
precipitation of the product
by gradual cooling and treatment with water/secondary butyl alcohol, and
subsequent filtration to yield 3,3-pentamethylene glutarimide;
is Treatment of 3,3-pentamethylene glutarimide with sodium hydroxide in an
aqueous solution up to dissolution, dripping the solution obtained into a
sodium
hydroxide/sodium hypochlorite mixture, which is also in an aqueous solution,
followed by acidification with hydrochloric acid to yield gabapentin
hydrochloride.
DETAILED DESCRIPTION OF THE INVENTION
2o The subject of the present invention is a process for the synthesis of
gabapentin
hydrochloride, comprising:
a) Reaction of a mixture of acetic anhydride/ammonium acetate with 1,1-
cyclohexane diacetic acid to yield 3,3-pentamethylene glutarimide;
b) Treatment of 3,3-pentamethylene glutarimide with sodium hydroxide in an
2s, aqueous solution up to dissolution, dripping the solution obtained into a
sodium
hydroxide/sodium hypochlorite mixture, which is also aqueous, followed by
acidification with hydrochloric acid to yield gabapentin hydrochloride.
The reaction of step ~a) is carried out at a temperature of 160°C to
170°C, up to
elimination by distillation of the acetic acid that has formed. Extinguishing
of the
3o reaction of step a) is achieved by gradual cooling, first at a temperature
of 90°C
110°C, with consequent addition to the reaction environment of a
water/secondary
butyl alcohol mixture, and subsequently, completing said cooling to room

CA 02500400 2005-03-29
WO 2004/031126 PCT/EP2003/010866
3
temperature. Extinguishing is completed by bringing the pH to a basic value;
namely, a pH of approximately 9 is reached by treating vvith 30% of aqueous
ammonia. Step a) according to the process object of the present invention
leads to
the synthesis of 3,3-pen~amethyl glutarimide with an average yield of 95%.
s In step b) the treatment of 3,3-pentamethyl glutarimide with sodium
hydroxide in
ari aqueous solution is preferably carried out at a temperature of between
50°C
and 80°C, in water with 30% sodium hydroxide. The resulting solution is
preferably
treated with a sodium hydroxide/sodium hypochlorite mixture present at a
temperature of between 0°C and 50°C, more preferably of between
0°C and 30°C,
io more in particular with a mixture wherein sodium hydroxide is 30% and
sodium
hypochlorite is 15%. Acidification, which is carried out at a temperature of
between
0°C and 50°C, preferably at room temperature, is preferably
carried out using
aqueous hydrochloric acid.
According to a further particularly preferred embodiment of the present
invention,
is in step b), acidification with hydrochloric acid is followed by a treatment
with an
aqueous solution of sodium bisulphite, under stirring at 40°C-
60°C; up to complete
elimination of the excess of chlorine, with recovery of the gabapentin
hydrochloride
by.filtration at 0°C, washing with ethyl acetate.
Provided below are some purely illustrative and non-limiting examples of the
2o present invention.
EXAMPLE 1: Preparation of 3,3-pentamethylene glutarimide
A flask is charged with 66.5 g of acetic anhydride, 66.5 g of ammonium
acetate,
and 100 g of 1,1-cyclohexane diacetic acid. The reaction mass is heated to
160°C-
170°C for eight hours, eliminating by distillation the acetic acid that
has formed. It
2s is cooled to 90°C-110°C, and 200 g of water and 100 g of
secondary butyl alcohol
are added. It then undergoes further cooling to room temperature, and the pH
is
brought to approximately 9 using 30% of aqueous ammonia. This is followed by
filtration, washing the solid with water. 87.7 g of dry 3,3-pentamethylene
glutarimide are obtained (yield 97%).
0 EXAMPLE 2: Preparation of gabapentin hydrochloride
A flask is charged with 100 g of 3,3-pentamethylene glutarimide, 200 g of
water,
and 81 g of 30% sodium hydroxide. It is heated to 50°C-80°C for
approximately

CA 02500400 2005-03-29
WO 2004/031126 PCT/EP2003/010866
4
two hours up to complete dissolution. The product is poured into a mixture
consisting of 400 g of 15% sodium hypochlorite and 162 g of 30% sodium
hydroxide, keeping the temperature of the system between 0°C and
30°C. It is left
to rest for approximately 3 hours at room temperature. The resulting solution
is
s then poured into 32% hydrochloric acid. The excess of chlorine is decomposed
by
treatment with an aqueous solution of sodium bisulphite, followed by stirring
at a
temperature of 40°-60°C for a few hours. Then it is cooled to
approximately 0°C,
filtering the solid and washing it with ethyl acetate. 95 g of gabapentin
hydrochloride are obtained with a yield of 88% and a degree of purity,
measured
io via HPLC, >99.5%.
Example 3: Preparation of Gabapentin form II
100g of gabapentin hydrochloride are solubilized in 500g of deionized water
and
90g of dicyclohexylamine are added while heating to 30°-50°C. An
abundant
precipitation of dicyclohexylamine hydrochloride is produced that is filtered
with a
is Buchner funnel. The dicyclohexylamine hydrochloride solid is treated with
sodium
hydroxide, thus regaining the dicyclohexylamine that is thus recovered and
recycled in the separation stage of the chloride ion by precipitation, while
the
aqueous solution contains gabapentin in free amino acid form.
The aqueous solution obtained by filtering is distilled under reduced
pressure, until
2o the start of precipitation, and the residue is taken back with ethyl
alcohol, heated to
40°-50°C, and the suspension obtained is cooled for a few hours
and filtered.
The solid obtained is vacuum dried at 30°-40°C, producing raw
gabapentin in the
polymorphic form "FORM II" with a formula (VI) impurity content of less than
0.05%. The yield is 80%
2s 50 g of raw gabapentin prepared as above described are suspended in 250 g
of
methyl alcohol and 125 g of isopropyl alcohol. It is heated under reflux for
30
minutes, and cooled at 20-25°C for two hours and subsequently at
0°C for a
further two hours. The suspension is filtered with a Buchner funnel and is
vacuum
dried at 30°-40°C, producing gabapentin of polymorphic form
"FORM II" with a
3o HPLC purity greater than 99.85%a content of lactam < 0.10% and .a content
of
chloride anions < 100 ppm.